Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
-
Intermap Expands Space Communications Infrastructure Contract
-
M&T Bank Expands Use of nCino with Adoption of Continuous Credit Monitoring Solution Powered by Rich Data Co’s Explainable AI Platform
-
Bread Financial™ Provides Performance Update for April 2024
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
VEON Publishes Annual Corporate Governance Report for Financial Year 2023
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
CLIF BAR Re-Launches “Loop the Lincoln” to Advance Organic Food and Farming Initiatives
-
Result of AGM
-
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
-
New University of Toronto Scarborough student residence becomes largest Passive House certified building in Canada
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
-
ATHA Energy Provides Update on 2024 Exploration Program
-
Guardian Capital Announces May 2024 Cash Distributions for Guardian Capital ETFs
-
BurgerFi Reports First Quarter 2024 Results
-
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
-
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
-
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
-
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
-
Bitfarms Reports First Quarter 2024 Results
-
Boralex announces a substantial 62% increase in net earnings and continued disciplined development of highly promising projects
-
Aya Gold & Silver Reports Q1-2024 Results; Maintains Guidance; Zgounder Expansion on Track
-
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
-
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Trevena Reports First Quarter 2024 Results and Provides Business Update
-
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
-
AYR Wellness Reports First Quarter 2024 Results
-
Penske Truck Leasing to Offer REE Automotive’s P7-C EV Trucks to its Customers for Demos and Orders Across North America
-
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference
-
Interface Systems Launches AI-Powered Voice-Down Solution with Integrated Remote Intervention
-
Bio-Path Holdings Reports First Quarter 2024 Financial Results
-
OTC Markets Group Welcomes Neometals Ltd. to OTCQX
-
Barrick’s Sustainability Strategy Delivers Real Value to Stakeholders
-
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
-
Unusual Machines to Host Q1 Earnings Call on May 15
-
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrators in 2024
-
Data Storage Corporation Reports 20% Increase in Revenue and Again Achieves Profitability for the 2024 First Quarter
-
Zapata AI Announces First Quarter 2024 Financial Results and Provides Business Update
-
OTC Markets Group Introduces Overnight Trading
-
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
-
OTC Markets Group Welcomes Butler National Corporation to OTCQX
-
Sportradar Reports First Quarter 2024 Financial and Operating Results
-
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
-
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
-
Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University
-
Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results
-
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
-
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
-
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference


